Promising drug cocktail aims to stop breast cancer recurrence
Disease control
Recruiting now
This study is for people with a type of breast cancer (hormone receptor-positive, HER2-negative) that has come back in the same area after initial treatment. The goal is to see if adding the drug ribociclib to standard hormone therapy can help prevent the cancer from returning ag…
Phase: PHASE2 • Sponsor: Oana Danciu • Aim: Disease control
Last updated May 26, 2026 12:08 UTC